NCT07225153 Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis
| NCT ID | NCT07225153 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aga Khan University |
| Condition | Malnutrition (Calorie) |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-08-30 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-08-30 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if Goat Milk-Derived Formula Alternatives (GMDFA) are safe and effective for infants who are unable to be exclusively breastfed. It will also study growth patterns, biological markers, and gut microbiome differences among infants receiving GMDFA, undiluted goat milk, or breast milk. The main questions it aims to answer are: 1. Do infants receiving GMDFA show similar growth patterns to those who are breastfed? 2. Are biological markers of gut health and nutrition (such as calprotectin, lipocalin-2, CRP, and claudin) comparable between the groups? 3. How do feeding types (GMDFA, goat milk, or breast milk) influence the infant gut microbiome composition, metabolic pathways, and lipid profiles? 4. Is GMDFA a safe and nutritionally adequate feeding option for infants unable to be exclusively breastfed? We will compare GMDFA, undiluted goat milk, and breast milk (reference group) to evaluate infant growth, gut health, and metabolic outcomes. Participants will: Be randomly assigned to one of three feeding groups: GMDFA, undiluted goat milk, or breastfed Attend regular follow-up visits for growth measurements and sample collection (blood, stool, and breast milk where applicable) Have feeding practices monitored and recorded through caregiver interviews and feeding logs Additional Analyses: Microbiome analysis: to identify gut bacterial diversity and composition across feeding groups Metagenomic analysis: to explore functional genes and metabolic pathways related to nutrition and gut health Lipidomic analysis: to assess differences in lipid and fatty acid profiles in breast milk, goat milk, and infant samples
Eligibility Criteria
Inclusion Criteria: * • Infants aged = 08 -10 weeks with WAZ better than -1.8. (NIPS \& ICF, 2019) Age Sex WAZ Weight in Kilograms 2 Month Boys WAZ\>-1.8 4-5 kg 2 Month Girls WAZ\>-1.8 4-5 kg Table 3: WAZ scores * Living in Matiari District. * Who has access to goat milk in their households. * The Breastfeeding group: Women who exclusively breastfeeding and not giving and sort of formula or animal derived milk. * Intervention Group: Women who do not breastfeed at all or give goat milk to their infants (2-3 feeds per day). * No birth deformities Exclusion Criteria: * • Infant birth weight \< WAZ -1.8 i.e. weight-for-age based on established growth standards, such as the World Health Organization (WHO). * Birth deformities or disorders, such as genetic disorders, aerodigestive problems, or congenital anomalies. * Plan to migrate during the next six months. * We will exclude the women who exclusive breast feed and continue breast feeding for first 4 months. * If the child is enrolled or included in any other interventional trial. * Who does not have access to goat milk in their households. * Are medically disqualified: Any potential participant who is deemed medically unfit for enrollment, due to the presence of severe or unstable health conditions that could compromise safety or interfere with the study outcomes, will be excluded from participation
Contact & Investigator
Dr. junaid Iqbal, PhD
PRINCIPAL INVESTIGATOR
Aga Khan University
Frequently Asked Questions
Who can join the NCT07225153 clinical trial?
This trial is open to participants of all sexes, aged 8 Weeks or older, up to 10 Weeks, studying Malnutrition (Calorie). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07225153 currently recruiting?
Yes, NCT07225153 is actively recruiting participants. Contact the research team at nimra.mazhar@scholar.aku.edu for enrollment information.
Where is the NCT07225153 trial being conducted?
This trial is being conducted at Matiāri, Pakistan.
Who is sponsoring the NCT07225153 clinical trial?
NCT07225153 is sponsored by Aga Khan University. The principal investigator is Dr. junaid Iqbal, PhD at Aga Khan University. The trial plans to enroll 15 participants.